CFC-Containing Albuterol Phase-Out Review To Begin January 2003
Executive Summary
FDA will begin the phase-out process for CFC-containing albuterol and beclomethasone products after Jan. 20, 2003, when its final rule on ozone-depleting substances goes into effect
You may also be interested in...
Albuterol Transition To CFC-Free: Increased Cost Could Affect Patient Access
Increases in cost of albuterol inhalers due to the transition from chlorofluorocarbons to non-ozone depleting substances could affect patient access, members of FDA's Pulmonary-Allergy Drugs Advisory Committee suggested
Albuterol Transition To CFC-Free: Increased Cost Could Affect Patient Access
Increases in cost of albuterol inhalers due to the transition from chlorofluorocarbons to non-ozone depleting substances could affect patient access, members of FDA's Pulmonary-Allergy Drugs Advisory Committee suggested
Albuterol CFC Phase-Out Date Needed Now For HFA Ramp Up, Firms Says
A lack of a definitive date for the phase-out of chlorofluorocarbon propelled albuterol metered dose inhalers could delay ramp up of production of inhalers that use non ozone depleting substances, manufacturers suggested at the June 10 meeting of FDA's Pulmonary-Allergy Drugs Advisory Committee